Spectre Capital Corp. (the ‘Company’ or ‘Spectre’) is providing an update, further to its news release of September 9, 2020, on its proposed acquisition of Hemptown Organics Corp. (‘Hemptown’) (the ‘Transaction’). The Transaction, once complete, is expected to result in the reverse takeover of Spectre (thereafter, referred to as the ‘Resulting Issuer’) and will constitute Spectre's Qualifying Transaction under Policy 2.4 ­ Capital Pool Companies of the Exchange (the ‘CPC Policy’). In connection with the Transaction, it is expected that Geoff Balderson will resign as CFO of the Company.